![Sam Shrivastava](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Wayne Guida | M | - |
Ibis Therapeutics LLC
![]() Ibis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Ibis Therapeutics LLC is a pharmaceutical company that manufactures therapeutics. The company is based in Tampa, FL. The company was founded by William A. Glauser, Sam Shrivastava. Sam Shrivastava has been the CEO since incorporation. | - |
Julia Hallisey | F | - |
Ibis Therapeutics LLC
![]() Ibis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Ibis Therapeutics LLC is a pharmaceutical company that manufactures therapeutics. The company is based in Tampa, FL. The company was founded by William A. Glauser, Sam Shrivastava. Sam Shrivastava has been the CEO since incorporation. | - |
Bradlee Heckmann | M | - |
Asha Therapeutics LLC
![]() Asha Therapeutics LLC Pharmaceuticals: OtherHealth Technology Asha Therapeutics LLC is an American life sciences company that specializes in precision drug design using its Prism™ technology to create curative therapeutics for diseases with high unmet medical needs in neurology, oncology, and infectious disease. Asha Therapeutics is located in the US. The company's lead therapeutic programs, Asha-624 and Asha-091, are expected to enter clinical trials by mid-2024 and are disease-modifying therapeutics for indications in amyotrophic lateral sclerosis, Parkinson's disease, and ME/CFS and long COVID, respectively. | - |
Rainer Metcalf | M | - |
Asha Therapeutics LLC
![]() Asha Therapeutics LLC Pharmaceuticals: OtherHealth Technology Asha Therapeutics LLC is an American life sciences company that specializes in precision drug design using its Prism™ technology to create curative therapeutics for diseases with high unmet medical needs in neurology, oncology, and infectious disease. Asha Therapeutics is located in the US. The company's lead therapeutic programs, Asha-624 and Asha-091, are expected to enter clinical trials by mid-2024 and are disease-modifying therapeutics for indications in amyotrophic lateral sclerosis, Parkinson's disease, and ME/CFS and long COVID, respectively. | - |
William A. Glauser | M | - |
Ibis Therapeutics LLC
![]() Ibis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Ibis Therapeutics LLC is a pharmaceutical company that manufactures therapeutics. The company is based in Tampa, FL. The company was founded by William A. Glauser, Sam Shrivastava. Sam Shrivastava has been the CEO since incorporation. | 6 years |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
United States | 5 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Sam Shrivastava
- Personal Network